SOPHiA GENETICS Overview
Pro stress-test →SOPHiA GENETICS is a Swiss-founded data-driven medicine software company headquartered in Rolle, Switzerland that provides genomic and radiomic analysis for hospitals, laboratories, and biopharma institutions. The company transforms patient outcomes with AI-driven technology that converts complex data into actionable insights.
Strategic Profile
Pro stress-test →SOPHiA DDM™ Platform is one of the largest technology-agnostic networks of connected healthcare institutions worldwide and is currently used by more than 750 hospital, laboratory, and biopharma institutions globally. In March 2025, the company announced it had hit the milestone of 2 million genomic profiles analysed with its Sophia DDM platform.
Competitive Landscape
Pro stress-test →Competitors include Flatiron, Agilent Technologies, DNAnexus, Fabric Genomics, and Benchling. SOPHiA GENETICS differentiates through its multimodal data integration and decentralized architecture that enables local data processing while maintaining collective intelligence benefits.
Industry Context
SOPHiA GENETICS operates in Healthcare Technology / Precision Medicine / Data-Driven Diagnostics.
Key facts
Founded: 2011 · Headquarters: Rolle, Switzerland · Employees: 201-500 · Revenue: $73.3M · Market cap: $363M